CSBR
CSBR
NASDAQ · Life Sciences Tools & Services

Champions Oncology Inc

$4.93
+0.03 (+0.61%)
As of Sep 28, 10:23 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +497.4% upside
Low Target $20.89
Average Target $29.45
High Target $33.06
Current Price $4.93
Current
$4.93
Target
$29.45
$20.89 $29.45 avg $33.06
Scenario Analysis
Bear Case
$20.89
323.7%
Low target
Base Case
$29.45
+497.4%
Avg target
Bull Case
$33.06
+570.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$8.31
-40.7% from high
52-Week Low
$4.59
+7.4% from low
Target vs 52W High
$29.45
+254.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -45.6%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -30.4%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -63.1%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -69.4%
WAT
Waters Corp
Buy 31 65% $189.60 -57.2%
ILMN
Illumina Inc
Buy 28 57% $169.36 -37.7%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -89.0%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -63.7%